Celecoxib Supplier-Buyer Network — Trade Flow Analysis

Name: Celecoxib Supplier-Buyer Trade Network Dataset — 326+ Indian Exporters, 17+ Importers, 112+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Celecoxib supplier network, Celecoxib buyers, pharmaceutical export India, Celecoxib trade data

TransData Nexus

Celecoxib

India Pharmaceutical Trade Intelligence

$133.6M326 Suppliers112 CountriesHS 30049069

ExportsIndia → UNITED STATES49.9%India → PHILIPPINES10.2%

ImportsGERMANY → India$50.3M FRANCE → India$57.8K

#1 Supplier: UMEDICA LABORATORIES #1 Buyer: LIFESCIENCE LOGISTICS

Who Supplies Celecoxib? Top Manufacturers & Buyers 2026 — UMEDICA LABORATORIES PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1UMEDICA LABORATORIES PRIVATE LIMITED

UMEDICA LABORATORIES PRIVATE LIMITED is the first-largest Celecoxib exporter from India, with a market share of 17.8% and a total export value of $23.7M across 65 shipments. Their average shipment value of $364.9K is above the market average of $27.4K, suggesting premium or bulk contract pricing.

UMEDICA LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. LIFESCIENCE LOGISTICS is the dominant customer, accounting for 99.3% of this supplier's tracked business. Top customers include:

• LIFESCIENCE LOGISTICS — $23.5M across 65 shipments (99.3% of this supplier's total exports)

• NIVAGEN PHARMA — $92.8K across 0 shipments (0.4% of this supplier's total exports)

• Life Science Logisti — $46.0K across 0 shipments (0.2% of this supplier's total exports)

• LIFESCIENCE LOGISTICS — $27.1K across 0 shipments (0.1% of this supplier's total exports)

• TO THE ORDER — $9.0K across 0 shipments (0.0% of this supplier's total exports)

Key Insight: UMEDICA LABORATORIES PRIVATE LIMITED's per-shipment value of $364.9K is 1233% above the market average of $27.4K, consistent with large-order contracts or value-added formulations.

2MACLEODS PHARMACEUTICALS LTD

MACLEODS PHARMACEUTICALS LTD is the second-largest Celecoxib exporter from India, with a market share of 12.1% and a total export value of $16.1M across 184 shipments. Their average shipment value of $87.6K is above the market average of $27.4K, suggesting premium or bulk contract pricing.

MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. MACLEODS PHARMA USA ,INC is the dominant customer, accounting for 84.8% of this supplier's tracked business. Top customers include:

• MACLEODS PHARMA USA ,INC — $13.7M across 156 shipments (84.8% of this supplier's total exports)

• CONTROLLED MEDICATIONS LTD — $1.7M across 20 shipments (10.7% of this supplier's total exports)

• MACLEODS PHARMA USA ,INC — $347.8K across 4 shipments (2.2% of this supplier's total exports)

• MACLEODS PHARMA UK L — $198.0K across 2 shipments (1.2% of this supplier's total exports)

• PHARMACEUTICAL AND C — $187.4K across 2 shipments (1.2% of this supplier's total exports)

Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $87.6K is 220% above the market average of $27.4K, consistent with large-order contracts or value-added formulations.

3ALEMBIC PHARMACEUTICALS LIMITED

ALEMBIC PHARMACEUTICALS LIMITED is the third-largest Celecoxib exporter from India, with a market share of 6.6% and a total export value of $8.8M across 434 shipments. Their average shipment value of $20.2K is below the market average of $27.4K, reflecting a high-volume, competitive pricing strategy.

ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• J. KNIPPER & COMPANY, — $3.7M across 185 shipments (42.6% of this supplier's total exports)

• J. KNIPPER & COMPANY, — $2.2M across 110 shipments (25.4% of this supplier's total exports)

• J. KNIPPER & COMPANY, — $1.4M across 67 shipments (15.4% of this supplier's total exports)

• J. KNIPPER & COMPANY, — $1.0M across 50 shipments (11.5% of this supplier's total exports)

• ALEMBIC PHARMACEUTIC — $439.3K across 22 shipments (5.0% of this supplier's total exports)

Key Insight: ALEMBIC PHARMACEUTICALS LIMITED operates with high shipment frequency (434 shipments) at a per-shipment value of $20.2K, indicating a broad distribution network with many smaller, regular orders.

4CIPLA LIMITED

CIPLA LIMITED is the fourth-largest Celecoxib exporter from India, with a market share of 5.2% and a total export value of $6.9M across 384 shipments. Their average shipment value of $18.0K is below the market average of $27.4K, reflecting a high-volume, competitive pricing strategy.

CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• CIPLA USA INC UPS SUPPLY CHAIN SOL — $3.4M across 187 shipments (48.8% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $1.4M across 76 shipments (19.7% of this supplier's total exports)

• CIPLA USA INC UPS SUPPLY CHAIN SOL — $1.2M across 66 shipments (17.1% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $706.1K across 39 shipments (10.2% of this supplier's total exports)

• PRIORITY HEALTHCARE — $291.8K across 16 shipments (4.2% of this supplier's total exports)

Key Insight: CIPLA LIMITED operates with high shipment frequency (384 shipments) at a per-shipment value of $18.0K, indicating a broad distribution network with many smaller, regular orders.

5BDH HEALTHCARE PRIVATE LIMITED

BDH HEALTHCARE PRIVATE LIMITED is the fifth-largest Celecoxib exporter from India, with a market share of 2.8% and a total export value of $3.7M across 23 shipments. Their average shipment value of $161.7K is above the market average of $27.4K, suggesting premium or bulk contract pricing.

BDH HEALTHCARE PRIVATE LIMITED serves 1 named buyer in our database. NELPA LIFESCIENCES INC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• NELPA LIFESCIENCES INC — $3.7M across 23 shipments (100.0% of this supplier's total exports)

Key Insight: BDH HEALTHCARE PRIVATE LIMITED's per-shipment value of $161.7K is 490% above the market average of $27.4K, consistent with large-order contracts or value-added formulations.

6MICRO LABS LIMITED

MICRO LABS LIMITED is the fifth-largest Celecoxib exporter from India, with a market share of 2.2% and a total export value of $2.9M across 201 shipments. Their average shipment value of $14.7K is below the market average of $27.4K, reflecting a high-volume, competitive pricing strategy.

MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• E.P.DIS — $1.1M across 75 shipments (37.3% of this supplier's total exports)

• AL-KAWKAB SCIENTIFIC — $667.0K across 45 shipments (22.6% of this supplier's total exports)

• E.P.DIS — $503.4K across 34 shipments (17.1% of this supplier's total exports)

• EVERSANA LIFE SCIENCE SERVICES, LLC — $348.4K across 24 shipments (11.8% of this supplier's total exports)

• MICRO LABS GMBH — $330.2K across 23 shipments (11.2% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED operates with high shipment frequency (201 shipments) at a per-shipment value of $14.7K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Celecoxib imports from India, with a total trade value of $66.7M across 794 shipments — representing a 49.9% share of all Celecoxib exports. The average shipment value of $84.0K is above the global average of $27.4K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.

Named Celecoxib importers in United States: LIFESCIENCE LOGISTICS is the largest buyer, accounting for 37.0% ($24.7M) of this market's total imports.

• LIFESCIENCE LOGISTICS — $24.7M (37.0% of United States's total)

• MACLEODS PHARMA USA ,INC — $13.7M (20.5% of United States's total)

• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $5.7M (8.6% of United States's total)

Key Insight: United States's per-shipment average of $84.0K (207% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Celecoxib imports from India.

Primary Market

Secondary Market

2Philippines

Philippines ranks as the second-largest destination for Celecoxib imports from India, with a total trade value of $13.7M across 68 shipments — representing a 10.2% share of all Celecoxib exports. The average shipment value of $201.1K is above the global average of $27.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Celecoxib importers in Philippines: NELPA LIFESCIENCES INC is the largest buyer, accounting for 76.2% ($10.4M) of this market's total imports.

• NELPA LIFESCIENCES INC — $10.4M (76.2% of Philippines's total)

Key Insight: Philippines's per-shipment average of $201.1K (634% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Celecoxib imports from India.

Primary Market

Secondary Market

3Canada

Canada ranks as the third-largest destination for Celecoxib imports from India, with a total trade value of $7.1M across 110 shipments — representing a 5.3% share of all Celecoxib exports. The average shipment value of $64.2K is above the global average of $27.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Celecoxib importers in Canada: APOTEX INC, is the largest buyer, accounting for 21.6% ($1.5M) of this market's total imports.

• APOTEX INC, — $1.5M (21.6% of Canada's total)

• MARCAN PHARMACEUTICALS INC. — $1.0M (14.6% of Canada's total)

Key Insight: Canada's per-shipment average of $64.2K (134% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Celecoxib imports from India.

Primary Market

Secondary Market

4France

France ranks as the fourth-largest destination for Celecoxib imports from India, with a total trade value of $3.4M across 36 shipments — representing a 2.6% share of all Celecoxib exports. The average shipment value of $95.2K is above the global average of $27.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Celecoxib importers in France: E.P.DIS is the largest buyer, accounting for 46.4% ($1.6M) of this market's total imports.

• E.P.DIS — $1.6M (46.4% of France's total)

Key Insight: France's per-shipment average of $95.2K (248% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Celecoxib imports from India.

Primary Market

Secondary Market

5Germany

Germany ranks as the fifth-largest destination for Celecoxib imports from India, with a total trade value of $3.1M across 41 shipments — representing a 2.3% share of all Celecoxib exports. The average shipment value of $75.3K is above the global average of $27.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Celecoxib importers in Germany: MERCKLE GMBH is the largest buyer, accounting for 56.5% ($1.7M) of this market's total imports.

• MERCKLE GMBH — $1.7M (56.5% of Germany's total)

Key Insight: Germany's per-shipment average of $75.3K (175% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Germany is a key market for Celecoxib imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Celecoxib.
2.Flow Mapping: 326 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 4,880 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 112 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

4,880 Verified Shipments

326 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Celecoxib

Celecoxib

Who Supplies Celecoxib? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Celecoxib — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Celecoxib? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Celecoxib Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1UMEDICA LABORATORIES PRIVATE LIMITED

2MACLEODS PHARMACEUTICALS LTD

3ALEMBIC PHARMACEUTICALS LIMITED

4CIPLA LIMITED

5BDH HEALTHCARE PRIVATE LIMITED

6MICRO LABS LIMITED

From Indian Factories to Global Pharmacies — How Celecoxib Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Celecoxib Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Philippines

3Canada

4France

5Germany

People Also Ask — Celecoxib Supplier & Trade Network

Celecoxib Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology